Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,356 | 1,178 | 99.8% |
| Education | $40.15 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,996 | 108 | $0 (2024) |
| ABBVIE INC. | $1,974 | 137 | $0 (2024) |
| Novo Nordisk Inc | $1,746 | 122 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,333 | 88 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,193 | 69 | $0 (2024) |
| Lilly USA, LLC | $981.86 | 71 | $0 (2024) |
| Merck Sharp & Dohme LLC | $714.64 | 69 | $0 (2024) |
| PFIZER INC. | $703.84 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $581.94 | 42 | $0 (2024) |
| Amgen Inc. | $530.26 | 32 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,551 | 144 | ABBVIE INC. ($555.25) |
| 2023 | $2,425 | 148 | AbbVie Inc. ($442.23) |
| 2022 | $2,645 | 156 | ABBVIE INC. ($462.16) |
| 2021 | $2,347 | 147 | AbbVie Inc. ($418.91) |
| 2020 | $1,948 | 117 | AstraZeneca Pharmaceuticals LP ($367.89) |
| 2019 | $2,493 | 179 | AstraZeneca Pharmaceuticals LP ($267.41) |
| 2018 | $1,955 | 144 | AstraZeneca Pharmaceuticals LP ($231.32) |
| 2017 | $2,032 | 146 | AstraZeneca Pharmaceuticals LP ($304.12) |
All Payment Transactions
1,181 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Cardio-renal | ||||||
| 12/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $31.03 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: PAIN | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ETONOGESTREL | ||||||
| 10/18/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Diagnostics | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 464 | 706 | $123,468 | $30,621 |
| 2022 | 15 | 572 | 851 | $122,650 | $31,233 |
| 2021 | 15 | 689 | 1,042 | $141,875 | $52,557 |
| 2020 | 13 | 551 | 856 | $105,367 | $40,993 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 118 | 238 | $62,356 | $12,906 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 121 | 187 | $34,595 | $8,619 | 24.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 33 | $2,970 | $2,367 | 79.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 42 | 42 | $11,214 | $2,293 | 20.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $5,100 | $1,386 | 27.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 34 | $1,360 | $1,055 | 77.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,964 | $937.55 | 31.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 43 | 43 | $1,634 | $790.86 | 48.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $385.00 | $114.45 | 29.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 24 | 32 | $576.00 | $109.12 | 18.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 58 | $313.50 | $42.11 | 13.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 129 | 223 | $58,426 | $10,836 | 18.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 185 | $34,225 | $8,227 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 46 | 46 | $12,282 | $3,075 | 25.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 43 | $3,825 | $2,869 | 75.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 40 | 40 | $1,590 | $1,210 | 76.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 27 | 27 | $2,160 | $1,081 | 50.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 50 | 50 | $1,900 | $964.02 | 50.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 13 | 22 | $3,125 | $835.49 | 26.7% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 19 | 20 | $1,600 | $808.60 | 50.5% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 14 | 15 | $815.00 | $457.59 | 56.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 12 | 13 | $461.70 | $394.23 | 85.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 11 | 11 | $660.00 | $164.42 | 24.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 16 | $560.00 | $163.04 | 29.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 16 | 120 | $660.00 | $82.50 | 12.5% |
About Dr. Kent Schreiber, MD
Dr. Kent Schreiber, MD is a Family Medicine healthcare provider based in Thornton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235276528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Schreiber, MD has received a total of $18,397 in payments from pharmaceutical and medical device companies, with $2,551 received in 2024. These payments were reported across 1,181 transactions from 86 companies. The most common payment nature is "Food and Beverage" ($18,356).
As a Medicare-enrolled provider, Schreiber has provided services to 2,276 Medicare beneficiaries, totaling 3,455 services with total Medicare billing of $155,404. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Thornton, CO
- Active Since 01/30/2007
- Last Updated 07/14/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1235276528
Products in Payments
- VRAYLAR (Drug) $970.54
- JARDIANCE (Drug) $959.39
- FARXIGA (Drug) $852.90
- Ozempic (Drug) $741.20
- TRELEGY ELLIPTA (Drug) $583.87
- UBRELVY (Drug) $575.92
- SYMBICORT (Drug) $464.14
- XARELTO (Drug) $439.23
- JANUVIA (Drug) $370.61
- NURTEC ODT (Drug) $330.21
- Kerendia (Drug) $296.38
- EMGALITY (Drug) $295.54
- CHANTIX (Drug) $287.77
- MOUNJARO (Drug) $274.51
- XIFAXAN (Drug) $262.77
- TRULICITY (Drug) $258.25
- ENTRESTO (Drug) $245.90
- Prolastin-C Liquid (Biological) $235.51
- ANORO (Drug) $229.37
- EVENITY (Biological) $223.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Thornton
Dr. Kenneth Hahn, Do, DO
Family Medicine — Payments: $21,946
Dr. Philip Rosenblum, Md, MD
Family Medicine — Payments: $19,181
Dr. Suzanne Nash, Md, MD
Family Medicine — Payments: $16,812
James Weingart, Md, MD
Family Medicine — Payments: $13,329
Ann Imhof, Md, MD
Family Medicine — Payments: $12,668
Nancy Stoudt, Md, MD
Family Medicine — Payments: $10,008